Daily as of 3 Nov 16:00 ET
- Price
- above both $11.11 vs 50 $10.05 / 200 $10.90
- Projection
- 🟨Golden cross projected in 15 bars
- Test
- No active test
- Last cross
- 💀Death cross 27 Feb 2026 · projected 22 bars out · tested 2 bars
ADMA | ADMA BiologicsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$11.11
+$0.05 (+0.45%)
ADMA Biologics (ADMA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Feb 2026, but the two have been closing on each other and a golden cross is projected within 20 bars. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two. On the weekly a death cross is projected within 10 bars.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $11.41 vs 50 $12.20 / 200 $11.26
- Projection
- 💀Death cross projected in 6 bars
- Test
- No active test
- Last cross
- 🟨Golden cross week of 27 Feb 2023 · projected 20 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $11.11 vs 50 $10.68 / 200 $9.51
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 20 Aug 2026 · projected 18 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 20 Aug 2026 | 🟨Golden | 4-hour | 18 bars out | Not tested |
| 27 Feb 2026 | 💀Death steep | daily | 22 bars out | 2 bar cross test |
| 19 Feb 2026 | 💀Death | 4-hour | 25 bars out | Not tested |
| 20 Jan 2026 | 🟨Golden moderate | daily | 29 bars out | Not tested |
| 3 Dec 2025 | 🟨Golden | 4-hour | 26 bars out | Not tested |
About ADMA
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$25.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid